Jianlin Song (Of Counsel-San Francisco, CA) presented “Post-COVID-19 Regulation and Litigation” at the Medmarc Insurance 33rd Medical Device Seminar held June 9‒11, 2021, in Coeur d'Alene, Idaho. Jianlin’s portion of the discussion included the U.S. Food and Drug Administration’s Emergency Use Authorization (EUA) program initiated during the COVID-19 pandemic to provide temporary, expedited approval of medical products for the U.S. market, including vaccines, prescription drugs and personal protective equipment. Many EUAs either will be terminated or revoked due to lack of effectiveness or high-risk side effects, and Jianlin emphasized the need for manufacturers and developers to monitor the status of their products to avoid product liability law suits.